Cargando…

Headache and botulinum toxin

The authors discuss clinical and international experience about botulinum toxins (BTX types A and B) in headache treatment. Data from literature suggest good results for the treatment of tensiontype headache, migraine and chronic tension–type headache. In the present paper mechanisms of action and i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Porta, M., Camerlingo, M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2005
Materias:	Headache: Therapeuric Choices
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3452016/ https://www.ncbi.nlm.nih.gov/pubmed/16362701 http://dx.doi.org/10.1007/s10194-005-0222-x

Ejemplares similares

Weight variations in the prophylactic therapy of primary headaches: 6–month follow–up
por: Maggioni, F., et al.
Publicado: (2005)

Prevalence of patent foramen ovale in a large series of patients with migraine with aura, migraine without aura and cluster headache, and relationship with clinical phenotype
por: Dalla Volta, G., et al.
Publicado: (2005)

Pharmacokinetics of sumatriptan in non-respondent and in adverse drug reaction reporting migraine patients
por: Sternieri, E., et al.
Publicado: (2005)

Risk–benefit and cost–benefit ratio in headache treatment
por: Pini, L. A., et al.
Publicado: (2005)

Headaches and obesity
por: Fortini, Ida, et al.
Publicado: (2022)

Behavioural intervention in medication overuse headache: A concealed double‐blind randomized controlled trial
por: Pijpers, Judith A., et al.
Publicado: (2022)

Multinational descriptive analysis of the real‐world burden of headache using the Migraine Buddy application
por: Goadsby, Peter J., et al.
Publicado: (2021)

Headache as an acute and post‐COVID‐19 symptom in COVID‐19 survivors: A meta‐analysis of the current literature
por: Fernández‐de‐las‐Peñas, César, et al.
Publicado: (2021)

When cluster headache was called histaminic cephalalgia (Horton’s headache)
por: Fanciullacci, M.
Publicado: (2006)

Headache advocacy
por: Grisold, Wolfgang, et al.
Publicado: (2023)

Medication–overuse headache: pathophysiological insights
por: Calabresi, P., et al.
Publicado: (2005)

Blunt Head Trauma and Headache
por: Chelse, Ana B., et al.
Publicado: (2015)

Neurophysiological approach to central pain modulation in primary headaches
por: Rossi, P., et al.
Publicado: (2005)

Cold extremities in migraine: a marker for vascular dysfunction in women
por: Linstra, K. M., et al.
Publicado: (2020)

Treatment with the monoclonal calcitonin gene‐related peptide receptor antibody erenumab: A real‐life study
por: de Vries Lentsch, Simone, et al.
Publicado: (2021)

Chronic daily headache in a paediatric headache centre
por: Scalas, C., et al.
Publicado: (2005)

Noninvasive vagus nerve stimulation and morphine transiently inhibit trigeminal pain signaling in a chronic headache model
por: Cornelison, Lauren E., et al.
Publicado: (2020)

Acute Migraine Therapy: New Drugs and New Approaches
por: Monteith, Teshamae S., et al.
Publicado: (2010)

Chronic migraine: Genetics or environment?
por: Chalmer, Mona Ameri, et al.
Publicado: (2021)

Long‐term efficacy and safety of erenumab in migraine prevention: Results from a 5‐year, open‐label treatment phase of a randomized clinical trial
por: Ashina, Messoud, et al.
Publicado: (2021)

Why are CGRP monoclonal antibodies not yet the first line treatment in migraine prevention?
por: Simioni, Caio Vinicius de Meira Grava
Publicado: (2022)

Update on Idiopathic Intracranial Hypertension Management
por: Souza, Marcio Nattan Portes, et al.
Publicado: (2022)

Vestibular migraine
por: Silva, Viviane Passarelli Ramin, et al.
Publicado: (2022)

It is time anti-CGRP monoclonal antibodies be considered first-line prophylaxis for migraine
por: Kubota, Gabriel Taricani
Publicado: (2022)

Erenumab in chronic migraine: Experience from a UK tertiary centre and comparison with other real‐world evidence
por: Khalil, Modar, et al.
Publicado: (2022)

First‐line steroid treatment for spontaneous intracranial hypotension
por: Tonello, Simone, et al.
Publicado: (2022)

Clinic and genetic predictors in response to erenumab
por: Zecca, Chiara, et al.
Publicado: (2022)

Functional connectivity changes in complex migraine aura: beyond the visual network
por: Silvestro, Marcello, et al.
Publicado: (2021)

Maintenance of response and predictive factors of 1‐year GalcanezumAb treatment in real‐life migraine patients in Italy: The multicenter prospective cohort GARLIT study
por: Vernieri, Fabrizio, et al.
Publicado: (2022)

Attachment styles and headache
por: Savi, L., et al.
Publicado: (2005)

Headache and mood disorders
por: De Filippis, S., et al.
Publicado: (2005)

Management of cluster headache in the Emergency Department
por: Di Sabato, F., et al.
Publicado: (2005)

Psychiatric comorbidity and chronicisation in primary headache
por: Gentili, C., et al.
Publicado: (2005)

Introduction to the History of Headache Section
Publicado: (2004)

Severe acute respiratory syndrome coronavirus 2 infection altered the factors associated with headache: evidence from a multicenter community-based case–control study
por: Ali, Mohammad
Publicado: (2022)

Headache among the educated in the century of enlightment
por: Zanchin, Giorgio, et al.
Publicado: (2004)

New additions to the History of Headache Section
por: Zanchin, Giorgio
Publicado: (2004)

Post–traumatic headache from moderate head injury
por: Moscato, D., et al.
Publicado: (2005)

Cost assessment of headache in childhood and adolescence: preliminary data
por: Mazzotta, G., et al.
Publicado: (2005)

Nontraumatic headache in the Emergency Department: a survey in the province of Trieste
por: Relja, G., et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_5hf9js930fhdacp32rmcnfs51m